iSpecimen (ISPC) Asset Writedowns and Impairment (2021 - 2026)
iSpecimen (ISPC) posted quarterly Asset Writedowns and Impairment of $368.0 for Q1 2026, down 99.67% year-over-year from $111041.0 in Q1 2025, and down 99.98% on a QoQ basis from $1.9 million in Q4 2025.
iSpecimen (ISPC) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
iSpecimen (ISPC) has reported Asset Writedowns and Impairment for 6 consecutive years, with $368.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 99.67% year-over-year to $368.0; the TTM figure through Mar 2026 stood at $1.8 million (up 184.47% YoY), while the FY2025 annual figure was $1.9 million, up 165.13% from the prior year.
- Asset Writedowns and Impairment came in at $368.0 for Q1 2026 at iSpecimen, down from $1.9 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $1.9 million in Q4 2025, with the low at -$234277.0 in Q4 2022.
- Average Asset Writedowns and Impairment over 5 years is $175810.4, with a median of $71213.0 recorded in 2022.
- Across the five-year window, Asset Writedowns and Impairment soared 1335.91% in 2022 and plunged 1519.12% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at -$234277.0 in 2022, then soared by 126.46% to $61986.0 in 2023, then surged by 706.57% to $499960.0 in 2024, then soared by 271.43% to $1.9 million in 2025, then slumped by 99.98% to $368.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $368.0, $1.9 million, and -$3521.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | iSpecimen | 931,959.22 | -1.89 Mn | -1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 368.00 |
| Mar 31, 2026 | 368.00 |
| Dec 31, 2025 | 1.86 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | -3,521.00 |
| Sep 30, 2025 | -3,521.00 |
| Jun 30, 2025 | -93,463.00 |
| Jun 30, 2025 | -93,463.00 |
| Mar 31, 2025 | 111,041.00 |
| Mar 31, 2025 | 111,041.00 |
| Dec 31, 2024 | 499,960.00 |
| Dec 31, 2024 | 499,960.00 |
| Sep 30, 2024 | 1,254.00 |
| Sep 30, 2024 | 1,254.00 |
| Jun 30, 2024 | 6,586.00 |
| Jun 30, 2024 | 6,586.00 |
| Mar 31, 2024 | 197,924.00 |
| Mar 31, 2024 | 197,924.00 |
| Dec 31, 2023 | 61,986.00 |
| Dec 31, 2023 | 61,986.00 |